Brief: ClearPoint Neuro Enrolls First Patient in Glioblastoma Trial Using Prism Neuro Laser Therapy System
12/12/2022 15:42
Dec 12 (Reuters) - Clearpoint Neuro Inc CLPT.O :
* CLEARPOINT NEURO ANNOUNCES FIRST PATIENT ENROLLED IN
GLIOBLASTOMA TRIAL USING CLEARPOINT PRISM™ NEURO LASER THERAPY
SYSTEM AT SKÅNE UNIVERSITY HOSPITAL IN SWEDEN
Source text for Eikon: ID:nGNX6WbLvN
Further company coverage: CLPT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clearpoint Neuro
See all newsClearpoint Neuro Inc reports results for the quarter ended June 30 - Earnings Summary
ClearPoint Neuro Q2 revenue rises 18% but misses estimates
Brief: ClearPoint Neuro Q2 Revenue USD 10.9 Million
ClearPoint Neuro Q1 revenue rises 43%, beats estimates
ClearPoint Neuro Q4 revenue rises on IRRAS acquisition